Moleculin Biotech (MBRX) Non-Current Assets (2016 - 2026)
Moleculin Biotech's Non-Current Assets came in at $12.36 million for Q2 2026, down 1.2% from $12.52 million a year earlier.
Powered by 
Analysis
Moleculin Biotech (MBRX) Non-Current Assets (2016 - 2026) Analysis & Trends
At the end of FY2025, Moleculin Biotech's Non-Current Assets was $12.44 million, up 6.0% from FY2024.
- Non-Current Assets carries a five-year compound annual growth rate of 1.0% (FY2020 to FY2025).
- Going back by year, Non-Current Assets was $11.73 million in FY2024 (-1.8%), $11.94 million in FY2023 (+1.0%), $11.83 million in FY2022 (+2.0%) and $11.59 million in FY2021 (-2.0%).
- The Q2 2026 figure represents the lowest quarterly Non-Current Assets since Q1 2025.
- Year-over-year, Non-Current Assets increased in three of the last seven quarters, with growth averaging 1.7%.
- The fastest year-over-year change in Non-Current Assets over five years came in Q4 2025 (growth of 6.0%), and the weakest in Q3 2021 (a decline of 2.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,138.33 Bn | 1,106.91 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 618.82 Bn | 537.35 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.36 Bn | 476.47 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 369.59 Bn | 323.96 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.57 Bn | 262.56 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.25 Bn | 234.94 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.35 Bn | 192.75 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.27 Bn | 165.47 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.03 Bn | 116.68 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Moleculin Biotech | 34.99 Mn | 4.59 Mn | - | 12.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.36 Mn |
| Dec 31, 2025 | 12.44 Mn |
| Sep 30, 2025 | 12.47 Mn |
| Jun 30, 2025 | 12.52 Mn |
| Mar 31, 2025 | 11.67 Mn |
| Dec 31, 2024 | 11.73 Mn |
| Sep 30, 2024 | 11.79 Mn |
| Jun 30, 2024 | 11.84 Mn |
| Mar 31, 2024 | 11.89 Mn |
| Dec 31, 2023 | 11.94 Mn |
| Sep 30, 2023 | 11.92 Mn |
| Jun 30, 2023 | 11.74 Mn |
| Mar 31, 2023 | 11.77 Mn |
| Dec 31, 2022 | 11.83 Mn |
| Sep 30, 2022 | 11.88 Mn |
| Jun 30, 2022 | 11.93 Mn |
| Mar 31, 2022 | 11.54 Mn |
| Dec 31, 2021 | 11.59 Mn |
| Sep 30, 2021 | 11.63 Mn |
| Jun 30, 2021 | 11.70 Mn |
API Access
Moleculin Biotech Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=MBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "MBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=MBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();